Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd
301130.SZ · SHZ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -3.15 | 1.86 | -2.62 | 27.45 |
| FCF Yield | -3.95% | -3.05% | 0.55% | 0.82% |
| EV / EBITDA | 26.95 | 24.92 | 36.35 | 57.21 |
| Quality | ||||
| ROIC | 4.04% | 4.76% | 4.30% | 9.36% |
| Gross Margin | 76.52% | 80.26% | 81.63% | 83.65% |
| Cash Conversion Ratio | 1.35 | 1.08 | 1.65 | 1.13 |
| Growth | ||||
| Revenue 3-Year CAGR | 0.12% | -7.58% | -3.73% | 6,585,789.14% |
| Free Cash Flow Growth | -17.36% | -636.19% | -66.09% | -24.39% |
| Safety | ||||
| Net Debt / EBITDA | -2.61 | -4.34 | -3.46 | -1.91 |
| Interest Coverage | 430.22 | 1,185.56 | 1,776.64 | 1,669.64 |
| Efficiency | ||||
| Inventory Turnover | 2.15 | 1.63 | 2.27 | 0.00 |
| Cash Conversion Cycle | -0.28 | 70.59 | 194.59 | -48.73 |